New filing deadlines for Schedule 13G become effective on September 30. In October 2023, the SEC adopted new rules governing beneficial...

The recent case involving United Therapeutics' patent on Tyvaso and Liquidia's Yutrepia sheds light on the complexities of patent law....

Recent cases show the U.S. Patent and Trademark Office director's interest in using director review to address substantive issues like...

The Court of Appeals for the Federal Circuit has sparked debate following a recent ruling on the Patent Trial and Appeal Board's (PTAB)...

The federal government's recent False Claims Act suit against Georgia Tech highlights the importance of complying with cybersecurity...

Nasdaq is asking for the Securities and Exchange Commission's blessing to codify proposed standards of review governing appeals before...

Effective October 1, the U.S. Securities and Exchange Commission (SEC) will increase the registration fee rate from $147.60 per million...

United States Patent and Trademark Office Director Kathi Vidal's recent sanctions decisions have been notable for their seriousness and...

The Federal Trade Commission's controversial ban on noncompete agreements is getting competing receptions in federal court. A...

It's been a busy few weeks for the securities world. Read the latest issue of Fenwick's securities update and get up to speed on: The...

Life sciences companies are adding risk factor language in response to the U.S. Supreme Court overturning the Chevron Doctrine. As you...

Effective July 31, 2024, large accelerated filers must submit fee data in Inline XBRL format in registration statements, fee bearing...